Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FFMCD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,355
Award facts
- Contract value 100% obligated
- $11,355.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,355.01 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Cosentyx (secukinumab) Unready 300 mg pen injections in 2 mL formulations, with completion targeted for June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling value and extends through December 2026.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order for Cosentyx, a biologic immunosuppressant used to treat inflammatory conditions, aligns with the company's extensive track record fulfilling federal medical supply requirements across multiple therapeutic domains through the DLA Troop Support Medical prime vendor contract. The transaction demonstrates AmerisourceBergen's ongoing role in providing specialized healthcare commodities to the Defense Health Agency and other federal healthcare beneficiaries through flexible, competitively awarded contracting vehicles.
Quick answers
Who was awarded contract SPE2DB25FFMCD?
SPE2DB25FFMCD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FFMCD worth?
The government has obligated $11,355 on SPE2DB25FFMCD.
Is contract SPE2DB25FFMCD an order under another contract?
Yes. SPE2DB25FFMCD is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB25FFMCD competed?
The extent of competition for SPE2DB25FFMCD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award